RASONQUE
Active substance: daraxonrasib
TABLET, FILM COATED · DARAXONRASIB 150 mg/1
United StatesActive
Marketing holder: Revolution Medicines, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DARAXONRASIB · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-e9ca-7170-82a7-93836d2c1911,01a1208f-5bc9-7dae-a48f-c687a1dec4df;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 85219-104
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 85219-104 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 85219-104 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 85219-104 · Verified 2026-10-09 · open in source